Middlemiss; David
Patent Applications and Registrations
Patent applications and USPTO patent grants for Middlemiss; David.The latest application filed is for "aniline derivatives, their preparation and their therapeutic application".
- Middlemiss; David - Bishop's Storford GB
- MIDDLEMISS; David - Bishop's Storford Hertfordshire GB
- Middlemiss; David - Bishops Stortford GB
- Middlemiss; David - Stortford N/A GB
- Middlemiss; David - Paris FR
- Middlemiss; David - Herts GB
- Middlemiss; David - Hertfordshire GB
- Middlemiss; David - Hertsfordshire GB
- Middlemiss; David - Essex GB
- Middlemiss; David - Bishop's Stortford GB
- Middlemiss; David - Hertforshire GB
| Patent | Date |
|---|---|
| Aniline derivatives, their preparation and their therapeutic application Grant 9,624,159 - Feutrill , et al. April 18, 2 | 2017-04-18 |
| Aniline Derivatives, Their Preparation And Their Therapeutic Application App 20160199330 - FEUTRILL; John ; et al. | 2016-07-14 |
| Aniline derivatives, their preparation and their therapeutic application Grant 9,249,085 - Feutrill , et al. February 2, 2 | 2016-02-02 |
| Aniline Derivatives, Their Preparation And Their Therapeutic Application App 20140350019 - Feutrill; John ; et al. | 2014-11-27 |
| Triazole derivatives as kinase inhibitors Grant 8,883,820 - Wilson , et al. November 11, 2 | 2014-11-11 |
| Amino triazoles as PI3K inhibitors Grant 8,865,699 - Ramsden , et al. October 21, 2 | 2014-10-21 |
| Heterocyclic Compounds, Their Preparation And Therapeutic Application App 20130123271 - Middlemiss; David ; et al. | 2013-05-16 |
| Treatment of CRTH2-mediated diseases and conditions Grant 8,314,257 - Middlemiss , et al. November 20, 2 | 2012-11-20 |
| Treatment of CRTH2-mediated diseases and conditions Grant 8,198,314 - Middlemiss , et al. June 12, 2 | 2012-06-12 |
| Treatment of CRTH2-mediated diseases and conditions Grant 8,163,936 - Middlemiss , et al. April 24, 2 | 2012-04-24 |
| Treatment of CRTH2-mediated diseases and conditions Grant 8,163,931 - Middlemiss , et al. April 24, 2 | 2012-04-24 |
| Heterocyclic compounds App 20120041195 - Leriche; Caroline ; et al. | 2012-02-16 |
| Substituted Quinazoline Compounds App 20120004210 - Leriche; Caroline ; et al. | 2012-01-05 |
| Enzyme Inhibitors and the Use Thereof App 20110230555 - Middlemiss; David ; et al. | 2011-09-22 |
| Sulfonamides As Zap-70 Inhibitors App 20110098288 - Major; Jeremy ; et al. | 2011-04-28 |
| Sulfamides As Zap-70 Inhibitors App 20110028405 - Harrison; Richard John ; et al. | 2011-02-03 |
| Amino Triazoles As Pi3k Inhibitors App 20110021497 - Ramsden; Nigel ; et al. | 2011-01-27 |
| Biaryl Amides App 20100331410 - Coleman; Robert ; et al. | 2010-12-30 |
| Peptidase inhibitors Grant 7,842,707 - Royalty , et al. November 30, 2 | 2010-11-30 |
| Triazole Derivatives As Kinase Inhibitors App 20100227800 - Wilson; Francis ; et al. | 2010-09-09 |
| Indolizine Acetic Acid Derivatives as CRTH2 Antagonists App 20100137300 - Hynd; George ; et al. | 2010-06-03 |
| Crth2 Antagonists App 20100010034 - Hynd; George ; et al. | 2010-01-14 |
| Indole, Benzimidazole, And Benzolactam Boronic Acid Compounds, Analogs Thereof And Methods Of Use Thereof App 20090264384 - Didsbury; John R. ; et al. | 2009-10-22 |
| Process for the identification of novel enzyme interacting compounds App 20090238808 - Drewes; Gerard ; et al. | 2009-09-24 |
| Compounds for the treatment of CRTH2-mediated diseases and conditions Grant 7,582,672 - Middlemiss , et al. September 1, 2 | 2009-09-01 |
| Indolizine Derivatives App 20090163534 - Hynd; George ; et al. | 2009-06-25 |
| Treatment of CRTH2-mediated diseases and conditions App 20090023788 - Middlemiss; David ; et al. | 2009-01-22 |
| Treatment of CRTH2-Mediated diseases and conditions App 20090018338 - Middlemiss; David ; et al. | 2009-01-15 |
| Treatment of CRTH2-mediated diseases and conditions App 20090018138 - Middlemiss; David ; et al. | 2009-01-15 |
| Treatment of CRTH2-mediated diseases and conditions App 20090018139 - Middlemiss; David ; et al. | 2009-01-15 |
| Compounds and Methods of Use Thereof App 20090005344 - Burns; James F. ; et al. | 2009-01-01 |
| Compounds and Methods of Use Thereof App 20080319044 - Didsbury; John R. ; et al. | 2008-12-25 |
| Indolizine Derivatives as Ligands of the Crth2 Receptor App 20080306109 - Hynd; George ; et al. | 2008-12-11 |
| Compounds and Methods of Use Thereof App 20080269204 - Dyakonov; Tatyana ; et al. | 2008-10-30 |
| Peptidase Inhibitors App 20080234292 - Royalty; Susan Marie ; et al. | 2008-09-25 |
| Compounds Having Crth2 Antagonist Activity App 20070232681 - Middlemiss; David ; et al. | 2007-10-04 |
| Treatment of CRTH2-mediated diseases and conditions App 20050119268 - Middlemiss, David ; et al. | 2005-06-02 |
| Ethanolamine derivatives Grant 4,908,386 - Finch , et al. March 13, 1 | 1990-03-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 